InauguralInvitation Only
Psoriasis
USFocus Meeting 2027
Two days, 48 people, one room.
September 10 to 11, 2027
Boston, MA
Dates
September 10-11, 2027
Two-day program
Venue
Boston, MA
Venue TBC
Audience
48 by invitation
24 KOLs & 24 fellows
Format
8 sessions · 24 talks
Expert talks + moderated panels
A Curated Room: The People Shaping Practice
This inaugural, invitation-only meeting convenes a deliberately small faculty: 24 leading psoriatic disease KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.
The science tracks where treatment is moving: biologic and oral selection across mechanisms, nonsteroidal topicals for high-impact sites, psoriatic arthritis interception, cardiometabolic risk in the dermatology clinic, and disease modification. Every session pairs expert talks with a moderated panel, sustained, close-quarters engagement rather than a lecture hall.
Biologics & Oral TherapiesIL-23 · IL-17 · TYK2Psoriatic ArthritisDisease ModificationNonsteroidal TopicalsCardiometabolic Risk · GPP
Meeting Co-Chairs
Jeffrey Cohen
Yale School of Medicine, New Haven, CT
Scott Elman
University of Miami Miller School of Medicine, Miami, FL
Faculty Drawn From
Yale · Mount Sinai · Penn · NYU Langone · Brigham and Women’s · The Rockefeller University and other leading US dermatology centers
48
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
14
Established US Focus Meetings behind it, a proven platform, not a one-off
Psoriasis US Focus Meeting 2027
Faculty
Listed alphabetically by surname
April Armstrong
UCLA David Geffen School of Medicine, Los Angeles, CA
Andrew Blauvelt
Blauvelt Consulting LLC, Lake Oswego, OR
Chris Bunick
Yale School of Medicine, New Haven, CT
Kristina Callis Duffin
University of Utah, Salt Lake City, UT
Jeffrey Cohen
Yale School of Medicine, New Haven, CT
William Damsky
Yale School of Medicine, New Haven, CT
Lawrence Eichenfield
UC San Diego / Rady Children’s Hospital, San Diego, CA
Scott Elman
University of Miami Miller School of Medicine, Miami, FL
Steven Feldman
Wake Forest School of Medicine, Winston-Salem, NC
Michael S. Garshick
NYU Langone Health, New York, NY
Joel Gelfand
University of Pennsylvania, Philadelphia, PA
Kenneth Gordon
Medical College of Wisconsin, Wauwatosa, WI
James Krueger
The Rockefeller University, New York, NY
Avery LaChance
Brigham and Women’s Hospital, Boston, MA
Mark Lebwohl
Icahn School of Medicine at Mount Sinai, New York, NY
Joseph Merola
UT Southwestern Medical Center, Dallas, TX
Arash Mostaghimi
Brigham and Women’s Hospital, Boston, MA
Alexis Ogdie
University of Pennsylvania, Philadelphia, PA
Jose Scher
NYU Langone Health, New York, NY
Mona Shahriari
Central Connecticut Dermatology, Cromwell, CT / Yale School of Medicine, New Haven, CT
Eingun James Song
Frontier Dermatology, Mill Creek, WA
Jennifer Soung
Southern California Dermatology, Santa Ana, CA
Linda Stein Gold
Henry Ford Health, Detroit, MI
Bruce Strober
Yale School of Medicine, New Haven, CT / Central Connecticut Dermatology, Cromwell, CT
Two Days, Eight Sessions
Agenda
Presentations15 min
Panel Discussions30 min
Lunch50 min
Day One · Friday, September 10, 2027
Session IInjectable Biologics for PsO
Moderator
Overview of Biologics
Bruce StroberYale School of Medicine, New Haven, CT / Central Connecticut Dermatology, Cromwell, CT
Biologic Selection
Mark LebwohlIcahn School of Medicine at Mount Sinai, New York, NY
Pipeline
Andrew BlauveltBlauvelt Consulting LLC, Lake Oswego, OR
Session IIOral Therapies for PsO
Moderator
Overview of Oral Therapies
Linda Stein GoldHenry Ford Health, Detroit, MI
Selecting an Oral Therapy
Chris BunickYale School of Medicine, New Haven, CT
Pipeline
April ArmstrongUCLA David Geffen School of Medicine, Los Angeles, CA
Session IIITopical Therapies for PsO
Moderator
Overview of Topical Therapies
Mona ShahriariCentral Connecticut Dermatology, Cromwell, CT / Yale School of Medicine, New Haven, CT
Topicals for High-Impact Sites: Genital, Intertriginous, Scalp & Face
Jennifer SoungSouthern California Dermatology, Santa Ana, CA
Adherence, Vehicle & Why Topicals Fail in the Real World
Steven FeldmanWake Forest School of Medicine, Winston-Salem, NC
Session IVPsoriatic Arthritis (PsA)
Moderator
Overview of Therapy
Joseph MerolaUT Southwestern Medical Center, Dallas, TX
Future Therapy
Alexis OgdieUniversity of Pennsylvania, Philadelphia, PA
Prevention of PsA
Jose ScherNYU Langone Health, New York, NY
Day Two · Saturday, September 11, 2027
Session VMetabolic Aspects of PsO
Moderator
Cardiovascular Disease in PsO: Overview
Michael S. GarshickNYU Langone Health, New York, NY
GLP-1s for Psoriatic Disease
Scott ElmanUniversity of Miami Miller School of Medicine, Miami, FL
Cardiovascular Disease Prevention in the Dermatology Clinic
Joel GelfandUniversity of Pennsylvania, Philadelphia, PA
Session VIHigh-Impact Sites / Other Treatment Considerations
Moderator
High-Impact Site Psoriasis
Jeffrey CohenYale School of Medicine, New Haven, CT
Pediatric Psoriasis
Lawrence EichenfieldUC San Diego / Rady Children’s Hospital, San Diego, CA
Special Populations: Pregnancy & Chronic Infection
Eingun James SongFrontier Dermatology, Mill Creek, WA
Session VIIDisease Modification and the Treatment Window
Moderator
Inflammatory Memory: Why the Plaque Returns in the Same Place
James KruegerThe Rockefeller University, New York, NY
Early Intervention and the Window of Opportunity: Cohort & Registry Data
Kristina Callis DuffinUniversity of Utah, Salt Lake City, UT
Drug Withdrawal, Tapering & Dose Spacing: Who Can Stop and Who Cannot
Kenneth GordonMedical College of Wisconsin, Wauwatosa, WI
Session VIIISpecial Topics in Psoriatic Disease
Moderator
Personalized Medicine for PsO
William DamskyYale School of Medicine, New Haven, CT
Access, Cost & Care Delivery in Psoriatic Disease
Avery LaChanceBrigham and Women’s Hospital, Boston, MA
Generalized Pustular Psoriasis (GPP)
Arash MostaghimiBrigham and Women’s Hospital, Boston, MA
Partnership Opportunities Now Open
Bespoke engagement packages for a closed, invitation-only audience
Request the Prospectus →
Your Point of Contact
Tania Lifanova
Account Executive, MD Education
tania.lifanova@md-education.com